Related Experiment Video
Updated: Jun 26, 2026
06:34
Laser-Induced Chronic Ocular Hypertension Model on SD Rats
Published on: December 4, 2007
Routine, single session, indirect laser for proliferative diabetic retinopathy.
1Department of Ophthalmology, Taunton and Somerset NHS Trust, Musgrove Park Hospital, Somerset, UK.
Eye (London, England)
|January 13, 2009
Summary
Indirect panretinal photocoagulation (PRP) for proliferative diabetic retinopathy showed good visual outcomes and low adverse events. This treatment is comparable to national standards for managing diabetic retinopathy.
Area of Science:
- Ophthalmology
- Diabetic Retinopathy Management
- Laser Therapy
Background:
- Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss.
- Panretinal photocoagulation (PRP) is a standard treatment for PDR.
- Indirect PRP is an alternative laser modality for PDR treatment.
Purpose of the Study:
- To assess visual and morphological outcomes of indirect PRP for PDR.
- To evaluate adverse events within 8 weeks of indirect PRP.
- To compare outcomes with national data.
Main Methods:
- Retrospective review of 107 patients undergoing indirect PRP.
- Exclusion of patients with prior PRP.
- Follow-up data collected around 9 months post-treatment.
Main Results:
- 14% of patients experienced adverse events within 8 weeks.
- Adverse events included retinal detachments, vitreous hemorrhages, and macular edema.
- No significant difference in retinal detachment or hemorrhage rates compared to national audit, but higher vitrectomy rate.
Conclusions:
- Indirect PRP demonstrated non-inferior visual and morphological outcomes for PDR.
- The incidence of significant PRP-induced adverse events was low.
- Outcomes were comparable to national data, with a higher vitrectomy rate due to early intervention policy.
